GENE ONLINE|News &
Opinion
Blog

2017-11-23|

November 23, 2015: Stanford Scientists Proved the Importance of lincRNAs in Human Embryo Development

by GeneOnline
Share To

November 23, 2015, researchers from Stanford University published a study on Nature Genetics demonstrating the importance of primate-specific noncoding RNA, human pluripotency-associated transcripts 2, 3 and 5 (HPAT2, HPAT3 and HPAT5), during human preimplantation development and nuclear reprogramming. Large primate-specific long intergenic noncoding RNA (lincRNA) families modulate gene expression during development and differentiation to reinforce cell fate. CRISPR-mediated disruption of the genes for these lincRNAs in pluripotent stem cells, followed by whole-transcriptome analysis, identifies HPAT5 as a key component of the pluripotency network.

Reference
https://www.ncbi.nlm.nih.gov/pubmed/26595768

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal Centered Around RNA-Targeted Drug Discovery
2024-09-06
Orna Therapeutics Secures Multi-Billion RNA Deal With Merck After $221 Million Series B
2022-08-17
Single Cell Sequencing – the Current Players
2022-08-04
LATEST
Bio Asia Pacific 2024 Close ASEAN Collaborations: Catalyzing Innovation and Global Partnerships
2024-09-12
Illumina’s IVD Biomarker Test Becomes the First FDA-approved Pan-cancer Companion Diagnostics Kit
2024-09-11
Lotus Pharma Expands in Southeast Asia with Alpha Choay Acquisition from Sanofi
2024-09-06
Indian CDMO Stocks in the Spotlight: US House to Vote on BIOSECURE Act Next Week
2024-09-06
Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal Centered Around RNA-Targeted Drug Discovery
2024-09-06
Illumina Wins EU Court Battle, Dodges Fine, but Grail Deal Already Void
2024-09-05
Breaking New Ground for Clinical Trials with AI/ML Applications
2024-09-05
EVENT
2024-09-13
ESMO Congress 2024
Barcelona, Spain
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
Scroll to Top